1. Introduction Orphan drugs and rare diseases are at the forefront of modern pharmaceutical innovation, providing hope for patients with previously untreatable or overlooked conditions. Türkiye, with its strategic healthcare reforms and a growing commitment to personalized medicine, has taken steps to develop a legal and regulatory environment supporting the development, registration, and access to […]
1. Introduction Türkiye stands as a gateway between Europe, Asia, and the MENA region—making it a highly attractive market for global pharmaceutical companies. With its robust healthcare system, growing population, and dynamic regulatory environment, Türkiye presents both tremendous opportunities and significant compliance challenges for foreign drug manufacturers, distributors, and investors. This article provides an essential […]
1. Introduction: Türkiye’s Pharma Market on the Rise Türkiye’s pharmaceutical industry stands at a unique crossroads of rapid domestic growth and increasing international relevance. With a population of over 85 million, a robust healthcare infrastructure, and a strategically central location bridging Europe and Asia, Türkiye offers both significant market potential and a dynamic export platform.In […]